Post-approval studies (Phase 4)Study completedNCT03767738
What this trial is testing
Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
Who this might be right for
Chorioretinal Vascular Disease
Regeneron Pharmaceuticals 65
Showing 8 of 8 results